Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
G0
G2
gap 1 (G1)
GARFT
gastrointestinal (GI) Multiple Myeloma as a Paradigm for Multi-Targeted Intervention Question 3.1 Answer 3.1 Pyrimidine Analogs
GFR
GITR
glioblastoma multiforme (GBM) Answer 2.4 Question 2.4 Answer 2.3 Question 2.3 Triazines (Three Attached Nitrogen Atoms)
Gln
glucocorticoid-induced TNF receptor-related protein (GITR)
glutamine (Gln) Answer 3.7 Asparaginases, as Amidohydrolases, Possess Both Asparaginase and Glutaminase Activity
glycinamide ribonucleotide formyltransferase (GARFT)
GnRH
GnRHa
GnRHRs
gonadotropin-releasing hormone (GnRH) Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer Question 10.4 Sources of and rogens in the Human Prostate Hormonal Agents and Combinations for Prevention and Treatment of ER Male Hormonal Therapies Schematic Structure of Gonadotropin-Releasing Hormone (GnRH) Agonist Relative to Native GnRH
good laboratory practice (GLP)
graft-versus-host disease (GVHD) prevention and treatment\|calcineurin-dependent mechanisms prevention and treatment\|defibrotide prevention and treatment\|methotrexate prevention and treatment\|posttransplant cyclophosphamide prevention and treatment\|tacrolimus prevention and treatment prevention and treatment\|calcineurin-independent mechanisms prevention and treatment\|high-dose cyclophosphamide prophylaxis prevention and treatment\|palifermin prevention and treatment\|sirolimus
GTP
G1
G6PD
gap 2 (G2)
GBM
GI
GLP
glucose-6-phosphate dehydrogenase (G6PD)
GMP
GnRH
GnRH receptors (GnRHRs)
gonadotropin-releasing hormone analogs (GnRHa)

NDX